Image from Google Jackets

Calcium antagonists in clinical medicine

By:

Epstein, M. (ed)

Publication details: Philadelphia Hanley and Belfus Inc. 2002Edition: 3rdDescription: 852; ill.,bibls.; BookFindISBN:

1560534966

Subject(s):

Summary: HardbackSummary: This thoroughly revised and expanded third edition presents modern knowledge of the diverse applications of calcium antagonists and makes recommendations about their appropriate use. New sections have been added on clinical pharmacology and metabolic effects. Sixteen new chapters have been added on such topics as pharmacogenetics of hypertension; using gene markers to infer pathogenesis and guide therapy; new pharmocologic directions for CCBs; calcium channel blocker use in end-stage renal disease; pharmocokinetics and pharmocodynamics; and others.

Holdings
Item type	Home library	Class number	Status	Date due	Barcode
Book	Newcomb Library at Homerton Healthcare Shelves	QV 150 EPS (Browse shelf(Opens below))	Available		10004

Browsing Newcomb Library at Homerton Healthcare shelves, Shelving location: Shelves Close shelf browser (Hides shelf browser)

Previous								Next
Previous	Quick Reference W 13 STE Stedman's medical dictionary.	QUICK REFERENCE ZWB 100 MOR Morton's medical bibliography: an annotated check-list of texts illustrating the history of medicine	QV 137 COP Smoking : what all healthcare professionals need to know	QV 150 EPS Calcium antagonists in clinical medicine	QV 150 OPI Drugs for the heart	QV 18.2 BOY Calculation skills for nurses / Claire Boyd	QV 18.2 BRO Pass the PSA /	Next

Hardback

This thoroughly revised and expanded third edition presents modern knowledge of the diverse applications of calcium antagonists and makes recommendations about their appropriate use. New sections have been added on clinical pharmacology and metabolic effects. Sixteen new chapters have been added on such topics as pharmacogenetics of hypertension; using gene markers to infer pathogenesis and guide therapy; new pharmocologic directions for CCBs; calcium channel blocker use in end-stage renal disease; pharmocokinetics and pharmocodynamics; and others.

There are no comments on this title.

to post a comment.